Rein Therapeutics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $3.2M | $12.9M | $17.3M | $5.2M | $3.6M | $7.0M | $5.3M | $10.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $4.3M | $13.7M | $18.3M | $21.9M | $48.2M | $16.3M | $19.6M | $21.8M |
| Property, Plant & Equipment | $0 | $1.0K | $19.0K | $70.0K | $128.0K | $15.0K | $295.0K | $7.3M |
| Goodwill | $6.3M | $6.3M | $6.3M | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $13.5M | $42.2M | $79.2M | — | — | — | — | — |
| Total Assets | $24.2M | $62.2M | $106.0M | $22.0M | $48.5M | $16.3M | $26.5M | $30.3M |
| Liabilities | ||||||||
| Accounts Payable | $4.0M | $911.0K | $1.2M | $1.7M | $1.2M | $1.6M | $1.5M | $1.7M |
| Total Current Liabilities | $6.2M | $5.7M | $4.4M | $3.4M | $4.5M | $4.0M | $5.8M | $5.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $7.2M | $7.8M | $7.7M | $3.4M | $4.6M | $4.2M | $10.4M | $10.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-401.3M | $-351.4M | $-288.5M | $-272.8M | $-245.5M | $-219.3M | $-198.1M | $-168.5M |
| Total Stockholders' Equity | $16.9M | $54.4M | $98.3M | $18.6M | $43.9M | $12.2M | $16.0M | $19.6M |